Seres Therapeutics, Inc. (MCRB)
Market Closed
17 Jul, 20:00
$
5. 33
+0.15
+2.8958%
$
52.78M Market Cap
- P/E Ratio
- Div Yield
56,400 Volume
-0.99 Eps
$ 5.18
Previous Close 
Analysts:
Want to track MCRB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Seres Therapeutics, Inc. (MCRB) Statistics
Valuation metrics
Market Cap 52.78M
Enterprise value 102.28M
Trailing P/E (ttm) -1.03
Forward P/E -0.93
PEG ratio 0
Price/Sales (ttm) 45
Price/Book (mrq) 1.93
Enterprise Value/Revenue 89.17
Enterprise Value/EBITDA -2.44
Overview
Shares outstanding 9.56M
Float 7.28M
Shares short 597.31K
% Held by insiders 0.12%
% Held by institutions 0.26%
Average volume (10 days) 70.41K
Average volume (90 days) 53.38K
Price summary
52-Week low 5.04
52-Week high 29.98
Beta 0.26
50-Day moving average 5.96
200-Day moving average 10.27
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 22 Apr 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -40.89%
Operating margin -76.41%
Operational effectiveness
Return on assets -0.4%
Return on equity -1.27%
Income Statement
Revenue (ttm) 789K
Revenue per share (ttm) 0.12
Quarterly revenue growth (yoy) -
Gross profit (ttm) -54.81M
EBITDA -89.84M
Net income to common (ttm) 5.7M
Diluted EPS (ttm) -4.89
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 45.77M
Total cash per share (mrq) 3.11
Total debt (mrq) 82.97M
Total Debt/Equity (mrq) 3.04
Current ratio (mrq) 1.65%
Book value per share (mrq) 2.77
Cash Flow
Cash flow statement 1.12M
Levered free cash flow (LFCF) -54.96M
